Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hans J. Hammers
Circulating Tumor DNA as a Marker of Therapeutic Response in Patients With Renal Cell Carcinoma: A Pilot Study
Clinical Genitourinary Cancer
Oncology
Urology
Related publications
A Multicenter Pilot Study Examining the Role of Circulating Tumor Cells as a Blood-Based Tumor Marker in Patients With Extensive Small-Cell Lung Cancer
Frontiers in Oncology
Cancer Research
Oncology
Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association With Clinical Outcomes: A Pilot Study
European urology oncology
Oncology
Radiology
Urology
Nuclear Medicine
Imaging
Surgery
The Tumor Marker for Renal Cell Carcinoma
Japanese Journal of Urology
Urology
Promoter Methylation of TRIM9 as a Marker for Detection of Circulating Tumor DNA in Breast Cancer Patients
SpringerPlus
Multidisciplinary
P082 Circulating Mir-145 as a Marker of Therapeutic Response in Patients With Ankylosing Spondylitis Receiving Anti-TNF Therapy
A Pilot Study of Antiangiogenic Therapy With Bevacizumab and Thalidomide in Patients With Metastatic Renal Cell Carcinoma
Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer Research
Allergy
Immunology
Pharmacology
KIM-1 as a Potential Serological/Urinological Tumor-Associated Marker of Renal Cell Carcinoma and Chemotherapy Nephrotoxicity
Onkourologiya
Oncology
Radiology
Urology
Nuclear Medicine
Nephrology
Imaging
Surgery
Role of PDL1 as a Prognostic Marker in Renal Cell Carcinoma: A Prospective Observational Study in Eastern India
Therapeutic Advances in Urology
Urology
Early Change in Circulating Tumor DNA as a Potential Predictor of Response to Chemotherapy in Patients With Metastatic Colorectal Cancer
Scientific Reports
Multidisciplinary
